The bioprocessing industry has been mainly studied and commercialized using batch and fed-batch production methods, while little focus has been given to continuous biomanufacturing. Nevertheless, at LeoRiosLab, we are convinced that the development of novel continuous bioprocessing methodologies which will greatly impact several industrial sectors such as the pharmaceutical, bioenergy and biomaterials industry.
Some advantages of continuous bioprocessing are reduction in cost, higher consistent product quality, higher automation and bioprocess control, bioprocess intensification and easiness to scale up. At LeoRiosLab, we aim to explore the challenges of continuous bioprocessing using microbial cell factories specifically engineered to grow in such conditions, in order to find novel solutions to reduce the barriers for its commercial implementation